Beijing Tongren Hospital

This study is testing a new drug, orelabrutinib, given alone or with an antibody drug, to treat people with marginal zone lymphoma who haven't had treatment before. The goal is to see if this approach, which avoids traditional chemotherapy, is effective and safe. About 88 partici…

This study is testing a new version of CAR-T cell therapy designed to attack lymphoma cells in two ways at once. It is for people whose large B-cell lymphoma has come back or hasn't responded to other treatments. The goal is to see if this dual-target approach is more effective a…

This study is testing two new designs of eyeglass lenses to see if they can slow down how quickly nearsightedness (myopia) gets worse in children. About 120 kids, aged 6 to 14, will wear one of the two lens types daily for a year and have regular eye check-ups. The main goal is t…

This study is testing whether adding a drug called zanubrutinib to standard chemotherapy can better control a fast-growing type of blood cancer called diffuse large B-cell lymphoma (DLBCL) in patients with high-risk features. It will enroll 50 newly diagnosed patients whose cance…

This study is testing a new antibody injection for people with seasonal allergies (like hay fever) whose symptoms are not well controlled by their current treatments. The injection works by blocking a specific protein (IL-4Rα) involved in the allergic reaction. About 120 particip…

This study aims to see if a quick, non-invasive scan of the back of the eye can reveal early signs of hardening of the arteries in people with high blood pressure, diabetes, or high cholesterol. Researchers will enroll 300 patients and follow them for five years, performing yearl…